XM无法为美国居民提供服务。
G
G

Gilead

交易方向

交易者偏好

技术摘要

每小时

市场新闻

Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries

Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries Oct 2 (Reuters) - Gilead Sciences GILD.O said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 low and lower-middle income countries. The U.S.-based drugmaker also plans to provide the companies branded version of the drug, lenacapavir, in 18 countries, such as Botswana, Ethiopia and Kenya, until t
G

EU withdraws marketing authorisation for Abbvie's hepatitis C drug

UPDATE 2-EU withdraws marketing authorisation for Abbvie's hepatitis C drug Adds background in paragraphs 5 to 7 Oct 1 (Reuters) - The European Medicines Agency said on Tuesday that it has withdrawn the marketing authorisation for Abbvie's ABBV.N hepatitis C drug Exviera at the request of the company. The regulator said it withdrew the authorisation on Sept.
G

Kailera jumps on weight-loss drug bandwagon with $400 mln early-stage funding

UPDATE 3-Kailera jumps on weight-loss drug bandwagon with $400 mln early-stage funding Adds comments from CEO interview in paragraphs 4 and 8 By Niket Nishant Oct 1 (Reuters) - Kailera Therapeutics launched on Tuesday as the latest startup seeking a slice of the booming market for anti-obesity therapies with a rare $400 million in early-stage funding.
G

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Sept 27 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 30-Sep-2024 AMC POCI.O Precision Optics Corporation Inc Q4 2024 Precision Optics Corporation Inc Earnings Release 30-Sep-2024 AMC TRAK Repositrak Inc Q4 2024 Park City Group Inc Earnings Release 30-Sep-2024 10:30 ENS EnerSys EnerSys Tech Talk: Lithi
G
N
P
U
L
M

FDA Says Gilead Issues Voluntary Nationwide Recall Of One Lot Of Veklury For Injection 100 Mg/Vial

BRIEF-FDA Says Gilead Issues Voluntary Nationwide Recall Of One Lot Of Veklury For Injection 100 Mg/Vial Sept 23 (Reuters) - FDA: FDA: GILEAD ISSUES VOLUNTARY NATIONWIDE RECALL OF ONE LOT OF VEKLURY (REMDESIVIR) FOR INJECTION 100 MG/VIAL DUE TO THE PRESENCE OF A GLASS PARTICLE FDA: GILEAD PRODUCT RECALLED IS LYOPHILIZED FORM OF VEKLURY FOR INJECTIO
G

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明